292 related articles for article (PubMed ID: 19349791)
21. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Kumar V; Ghosh B; Raina UK; Goel N
Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427
[No Abstract] [Full Text] [Related]
22. Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?
Biester S; Ziemssen F; Ulrich Bartz-Schmidt K; Gelisken F
Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1575-7. PubMed ID: 19582472
[No Abstract] [Full Text] [Related]
23. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
24. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Parravano M; Menchini F; Virgili G
Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
[TBL] [Abstract][Full Text] [Related]
25. Debate on the various anti-vascular endothelial growth factor drugs.
Khalili MR; Hosseini H
Indian J Ophthalmol; 2008; 56(3):255-6; author reply 256. PubMed ID: 18417837
[No Abstract] [Full Text] [Related]
26. [Treatment of neovascular age-related macular degeneration with bevacizumab].
Monzón Moreno A
Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199
[No Abstract] [Full Text] [Related]
27. VEGF inhibitors for AMD and diabetic macular edema.
Med Lett Drugs Ther; 2015 Mar; 57(1464):41-2. PubMed ID: 25758545
[No Abstract] [Full Text] [Related]
28. [Molecular targeting therapy for diabetic retinopathy].
Nakao S; Yoshida S; Enaida H; Ishibashi T
Nihon Rinsho; 2012 Nov; 70 Suppl 8():628-46. PubMed ID: 23513915
[No Abstract] [Full Text] [Related]
29. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of ocular neovascularization: promises and potential problems.
van Wijngaarden P; Coster DJ; Williams KA
JAMA; 2005 Mar; 293(12):1509-13. PubMed ID: 15784876
[No Abstract] [Full Text] [Related]
31. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.
Ho AC; Scott IU; Kim SJ; Brown GC; Brown MM; Ip MS; Recchia FM
Ophthalmology; 2012 Oct; 119(10):2179-88. PubMed ID: 22917890
[TBL] [Abstract][Full Text] [Related]
32. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
33. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab and macular edema.
Kumar A
Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
[No Abstract] [Full Text] [Related]
35. Anti-VEGF (vascular endothelial growth factor) drugs in diabetic macular oedema.
Chhablani JK
Eye (Lond); 2011 Feb; 25(2):254; author reply 254. PubMed ID: 21151038
[No Abstract] [Full Text] [Related]
36. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab.
Funk M; Schmidinger G; Maar N; Bolz M; Benesch T; Zlabinger GJ; Schmidt-Erfurth UM
Retina; 2010 Oct; 30(9):1412-9. PubMed ID: 20711086
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review.
Zechmeister-Koss I; Huic M
Br J Ophthalmol; 2012 Feb; 96(2):167-78. PubMed ID: 22133986
[TBL] [Abstract][Full Text] [Related]
38. Correspondence.
Rajpal S; Narula R; Agarwal M; Chaudhary SP
Retina; 2010; 30(7):1160; author reply 1160. PubMed ID: 20616693
[No Abstract] [Full Text] [Related]
39. Anti-VEGF Molecules for the Management of Diabetic Macular Edema.
Bandello F; Cicinelli MV; Parodi MB
Curr Pharm Des; 2015; 21(32):4731-7. PubMed ID: 26350530
[TBL] [Abstract][Full Text] [Related]
40. Emergency department visits after intravitreal bevacizumab and ranibizumab injections in diabetic patients.
Johnson D; Jagan L; Kurji A; Jumaa K; Sharma S
Can J Ophthalmol; 2014 Dec; 49(6):e146-8. PubMed ID: 25433751
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
